APS Accelerator modular systems, 208-230 V-, 50/60 Hz, 1800 VA, IVD, RX, Class 2 Laser Product,

FDA Device Recall #Z-2755-2019 — Class II — September 7, 2018

Recall Summary

Recall Number Z-2755-2019
Classification Class II — Moderate risk
Date Initiated September 7, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Abbott Laboratories, Inc
Location Irving, TX
Product Type Devices
Quantity 159 devices

Product Description

APS Accelerator modular systems, 208-230 V-, 50/60 Hz, 1800 VA, IVD, RX, Class 2 Laser Product,

Reason for Recall

The firm identified customer sites where modules which the safety pacemaker label is missing. Information regarding the label included in the Operations Manual has been updated to specify: 1) the risk of malfunction applies to anyone with a pacemaker who may work on these modules; 2) the minimum safety distance has increased to 200 mm (7.87") from transport mechanisms. Any person with a pacemaker must not get closer than this distance from modules axes.

Distribution Pattern

US: TX, VA, AZ, NV, MA, LA, MN, PA, SC, NJ, NY, CA, IL, IN, WA, FL, TN, PA, KS, ND, NC, CT OUS: Argentina, Australia, Belgium, Canada, China, Denmark, France, Greece, Hong Kong, Ireland, Italy, New Zealand, Norway, Oman, Pakistan, Philippines, Portugal, Russia, Saudi Arabia, Singapore, Spain, Taiwan, Turkey, UAE, UK, Venezuela

Lot / Code Information

All Lot Numbers ABT018 ABT070 ABT107 ABT135 ABT019 ABT074 ABT108 ABT136 ABT023 ABT075 ABT109 ABT137 ABT024 ABT077 ABT110 ABT138 ABT026 ABT078 ABT111 ABT139 ABT027 ABT081 ABT112 ABT140 ABT028 ABT082 ABT113 ABT142 ABT034 ABT083 ABT114 ABT143 ABT036 ABT084 ABT116 ABT144 ABT037 ABT086 ABT117 ABT145 ABT041 ABT088 ABT118 ABT146 ABT042 ABT089 ABT119 ABT147 ABT047 ABT091 ABT120 ABT149 ABT049 ABT092 ABT121 ABT150 ABT050 ABT093 ABT122 ABT151 ABT051 ABT094 ABT123 ABT152 ABT054 ABT096 ABT124 ABT153 ABT058 ABT097 ABT125 ABT154 ABT059 ABT098 ABT126 ABT156 ABT062 ABT099 ABT127 ABT157 ABT063 ABT100 ABT128 ABT158 ABT065 ABT101 ABT129 ABT159 ABT066 ABT102 ABT130 ABT067 ABT104 ABT131 ABT068 ABT105 ABT132 ABT069 ABT106 ABT133

Other Recalls from Abbott Laboratories, Inc

Recall # Classification Product Date
Z-0749-2022 Class II Alinity s System software version2.8.0, REF LN ... Feb 3, 2022
Z-2276-2021 Class II Alinity s System REF 06P16-01. An automated i... Jul 12, 2021
Z-1671-2020 Class II ARCHITECT C System Mixer - Product Usage: The A... May 1, 2019
Z-0971-2019 Class II ARCHITECT MAGNESIUM, (a) REF 7D70-21, (b) 7D70-... Jan 2, 2019
Z-1296-2019 Class II Abbott ARCHITECT cSystems ICT Module, REF 09D28... Aug 28, 2018

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.